AVAILABILITY OF ANTI-NEOPLASTIC MEDICINES ACROSS EUROPE: FIRST RESULTS OF THE ESMO-LED EUROPEAN CONS...

Implications of the findings from the ESMO study of regulatory barriers, cost and availability of anti-cancer agents for European oncologists and patients

A. Eniu